Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lung epithelial and endothelial cell death caused by pro-oxidant insults is a cardinal feature of acute lung injury/acute respiratory distress syndrome (ALI/ARDS) patients. The NF-E2-related factor 2 (NRF2) activation in response to oxidant exposure is crucial to the induction of several antioxidative and cytoprotective enzymes that mitigate cellular stress. Since prolonged exposure to
hyperoxia
causes cell death, we hypothesized that chronic
hyperoxia
impairs NRF2 activation, resulting in cell death. To test this hypothesis, we exposed nonmalignant small airway epithelial cells (AECs) to acute (1-12 h) and chronic (36-48 h)
hyperoxia
and evaluated cell death, NRF2 nuclear accumulation and target gene expression, and NRF2 recruitment to the endogenous
HMOX1
and NQO1 promoters. As expected,
hyperoxia
gradually induced death in AECs, noticeably and significantly by 36 h; ~60% of cells were dead by 48 h. However, we unexpectedly found increased expression levels of NRF2-regulated antioxidative genes and nuclear NRF2 in AECs exposed to chronic
hyperoxia
as compared to acute
hyperoxia
. Chromatin Immunoprecipitation (ChIP) assays revealed an increased recruitment of NRF2 to the endogenous
HMOX1
and NQO1 promoters in AECs exposed to acute or chronic
hyperoxia
. Thus, our findings demonstrate that NRF2 activation and antioxidant gene expression are functional during
hyperoxia
-induced lung epithelial cell death and that chronic
hyperoxia
does not impair NRF2 signaling overall.
...
PMID:The NRF2 activation and antioxidative response are not impaired overall during hyperoxia-induced lung epithelial cell death. 2373 42